Company Quick10K Filing
Amedisys
10-Q 2020-06-30 Filed 2020-07-29
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-10-30
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-31 Filed 2019-02-28
10-Q 2018-09-30 Filed 2018-10-30
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-02-28
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-05-03
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-03
10-Q 2016-03-31 Filed 2016-05-04
10-K 2015-12-31 Filed 2016-03-10
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-07-29
10-Q 2015-03-31 Filed 2015-04-29
10-K 2014-12-31 Filed 2015-03-04
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-07-30
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-12
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-07-31
10-Q 2013-03-31 Filed 2013-04-30
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-30 Filed 2011-11-01
10-Q 2011-06-30 Filed 2011-08-02
10-Q 2011-03-31 Filed 2011-04-26
10-K 2010-12-31 Filed 2011-02-22
10-Q 2010-09-30 Filed 2010-10-26
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-04-27
10-K 2009-12-31 Filed 2010-02-23
8-K 2020-07-28 Earnings, Regulation FD, Earnings, Exhibits
8-K 2020-06-09
8-K 2020-06-01
8-K 2020-05-06
8-K 2020-04-23
8-K 2020-04-10
8-K 2020-02-18
8-K 2020-01-14
8-K 2020-01-02
8-K 2019-11-25
8-K 2019-10-29
8-K 2019-10-17
8-K 2019-07-31
8-K 2019-07-25
8-K 2019-06-07
8-K 2019-04-30
8-K 2019-04-01
8-K 2019-02-27
8-K 2019-02-25
8-K 2019-02-19
8-K 2019-02-12
8-K 2019-02-01
8-K 2019-01-08
8-K 2018-10-29
8-K 2018-10-09
8-K 2018-10-03
8-K 2018-09-27
8-K 2018-08-29
8-K 2018-07-31
8-K 2018-07-31
8-K 2018-06-29
8-K 2018-06-06
8-K 2018-06-04
8-K 2018-05-18
8-K 2018-05-07
8-K 2018-04-20
8-K 2018-02-27
8-K 2018-01-10

Amedisys Financials

AMED Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CVS (CVS) 81,695 21% 12.7 2% 220,113 157,180 244,311 50,096 4,474 11,498 146,074
Walgreens Boots (WBA) 49,162 22% 7.3 7% 68,586 43,814 136,354 30,423 4,828 8,231 60,251
Chemed (CHE) 7,006 31% 32.9 13% 1,233 560 1,416 442 154 217 7,127
Teladoc (TDOC) 4,813 67% -61.8 -7% 1,568 575 520 350 -105 -70 4,338
Amedisys (AMED) 4,374 25.2 11% 1,212 609 0 0 127 182 4,597
MSA Safety (MSA) 4,255 46% 24.6 6% 1,699 991 1,389 632 106 183 4,518
Taro Pharmaceutical Industries (TARO) 4,157 0% 2,135 224 0 0 0 0 3,589
Repligen (RGEN) 4,036 55% 78.3 2% 1,379 334 253 140 23 49 3,801
BioScrip (BIOS) 2,306 28% -65.5 -3% 2,582 1,660 1,170 322 -84 -55 3,578
US Physical Therapy (USPH) 1,669 18% 26.1 8% 565 188 477 86 45 65 1,697
Addus HomeCare (ADUS) 1,266 27% 31.3 3% 619 149 598 162 20 35 1,087
Civitas Solutions (CIVI) 636 20% 8.1 1% 1,100 927 1,613 327 12 158 1,277
Concord Medical Services Holdings (CCM) 476 0% 4,585 2,312 0 0 0 0 191
Diplomat Pharmacy (DPLO) 384 6% -1.5 -56% 1,163 1,032 5,206 309 -649 -560 831
Rite Aid (RAD) 371 21% 19.0 -6% 10,530 9,494 21,624 4,634 -603 200 3,785
PetMed Express (PETS) 360 30% 7.6 18% 146 20 275 82 26 35 265
LHC Group (LHCG) 4 37% -0.2 4% 2,098 600 2,059 753 88 132 -26
111 (YI) 0% 1,546 323 0 0 0 0 -854
AdaptHealth (AHCO) -0.7 0% 257 11 0 0 0 1 -1

Balance Sheet ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash348211612812014928294841373915730441731168333572881093048596686120261420111421
Accounts Receivable15015115213614214215315114816216316316914512511111111511110399111110122125154152162166173173177201193198195189236240255
Inventory
PP&E9295112118139144144147243144146151270156157160289157148141284208217182184187184187176373433178159129124125303030
Assets1,1721,2221,2691,2641,3001,3281,3418478588558588767317127007557267277106826706236456666857067117227347578068008138427537267171,1841,2061,212
Accounts Payable17222320232122222521242229282224202419191624222426343533302929232523302529333636
Long-Term Debt1711631621531451361631531451371281221037975714743144114116989610010011194949392919091881286011314278244
Liabilities436438442416420423411335338325317304276251235377354364339299272256265272275295283275273274313286297293344280234663643609
Stockholders' Equity735783826847878902928511519529540555452460464377372363372384397367379393410410427445460482492512515548408444482520562603
Income Statement ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue204209206201191193206192209215214206193176179178177174170171171176187192202207212213216220227239238243250275291289
Gross Profit
R&D
SG&A121123124145152155
Tax2421181101450563132000555-08610477610-290101110111010
Net Income373222221522-4244543710-10732-91-10-12899-351191361112915515-427343228323434
Cash Flow ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating7154473453242837122322133234288-6-89255144331201215729273610405168205947
Cash Investing-14-13-14-32-16-136-17-12-10-18-12-20-17-7-11-11-5-40-5-2-10-8-48-34-4-8-7-8-23-1-3-2-7-329-19-4
Cash Financing-9-7-21-9-8-9-9-7-9-9-8-17-23-3-3-24-3102-313-17-31-22-9-0-1-1-2-2-3-143-73299-37-37